tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Advertisement

JW (Cayman) Therapeutics Co. Ltd. (2126) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
JW (Cayman) Therapeutics Co. Ltd.
HK$3.48
HK$1.57B
145.07%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$11.50
HK$11.53B
45.14
213.35%
0 Buy
0 Hold
0 Sell
Hold
Lepu Biopharma Co. Ltd. Class H
HK$6.47
HK$11.52B
-55.06
106.17%
Jiangsu Recbio Technology Co., Ltd. Class H
HK$6.68
HK$3.34B
-16.90%
CStone Pharmaceuticals
HK$6.26
HK$9.18B
-20.28
198.10%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$10.46
HK$7.11B
184.79
13.20%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
3.48
2.05
143.36%
HK:9966
Alphamab Oncology
11.50
7.63
197.16%
HK:2157
Lepu Biopharma Co. Ltd. Class H
6.35
3.27
106.17%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
6.98
-1.42
-16.90%
HK:2616
CStone Pharmaceuticals
6.26
4.21
205.37%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
10.46
1.28
13.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis